We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Sino Biological and Ainnocence have joined forces to establish an AI-enabled platform for antibody affinity maturation. Powered by a self-evolving artificial intelligence engine, Ainnocence’s SentinusAI™ is revolutionizing affinity maturation processes. SentinusAI™ can effectively rank up to 1010 antibody sequences based on their predicted affinity towards one or more antigens within a few days. Combined with the high-throughput recombinant antibody development program at Sino Biological, top candidates can be expressed recombinantly at a lower cost and shorter lead time to generate affinity data with a high hit rate of 15%.
Sino Biological is an international reagent supplier and contract research service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced with a stringent quality management system, and include unique bioreagents addressing areas such as cell therapy, stem cell, and infectious disease research. For example, Sino Biological has a wealth of viral antigens (Provir®) and corresponding antibodies, with one of the world’s Extensive collections. Sino Biological is also a well-recognized, qualified source of recombinant cytokines and high-quality GMP-grade cytokines. In addition, Sino Biological offers contract research production services for the custom development of full length, bioactive proteins and high-affinity antibodies, along with other services. To learn more about Sino Biological visit www.sinobiological.com, follow us on LinkedIn or @SinoInc on Twitter.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.